全文获取类型
收费全文 | 7867篇 |
免费 | 518篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 199篇 |
妇产科学 | 77篇 |
基础医学 | 919篇 |
口腔科学 | 322篇 |
临床医学 | 1008篇 |
内科学 | 1336篇 |
皮肤病学 | 46篇 |
神经病学 | 729篇 |
特种医学 | 275篇 |
外科学 | 845篇 |
综合类 | 498篇 |
一般理论 | 12篇 |
预防医学 | 940篇 |
眼科学 | 156篇 |
药学 | 644篇 |
中国医学 | 3篇 |
肿瘤学 | 357篇 |
出版年
2023年 | 44篇 |
2022年 | 63篇 |
2021年 | 162篇 |
2020年 | 95篇 |
2019年 | 139篇 |
2018年 | 202篇 |
2017年 | 127篇 |
2016年 | 160篇 |
2015年 | 163篇 |
2014年 | 224篇 |
2013年 | 345篇 |
2012年 | 587篇 |
2011年 | 668篇 |
2010年 | 348篇 |
2009年 | 307篇 |
2008年 | 562篇 |
2007年 | 656篇 |
2006年 | 582篇 |
2005年 | 591篇 |
2004年 | 570篇 |
2003年 | 568篇 |
2002年 | 480篇 |
2001年 | 93篇 |
2000年 | 67篇 |
1999年 | 68篇 |
1998年 | 96篇 |
1997年 | 55篇 |
1996年 | 41篇 |
1995年 | 42篇 |
1994年 | 37篇 |
1993年 | 45篇 |
1992年 | 24篇 |
1991年 | 20篇 |
1990年 | 21篇 |
1989年 | 16篇 |
1988年 | 13篇 |
1987年 | 11篇 |
1986年 | 18篇 |
1985年 | 11篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 7篇 |
1981年 | 3篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1976年 | 4篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1964年 | 2篇 |
排序方式: 共有8402条查询结果,搜索用时 0 毫秒
51.
Wenzel Mike Yu Hang Uhlig Annemarie Würnschimmel Christoph Wallbach Manuel Becker Andreas Fisch Margit Chun Felix K. H. Meyer Christian P. Leitsmann Marianne 《International urology and nephrology》2021,53(10):2041-2049
International Urology and Nephrology - To test the value of preoperative and postoperative cystatin C (CysC) as a predictor on kidney function after partial (PN) or radical nephrectomy (RN) in... 相似文献
52.
Nathan Perlis Antonio Finelli Mike Lovas Alejandro Berlin Janet Papadakos Sangeet Ghai Vasiliki Bakas Shabbir Alibhai Odelia Lee Adam Badzynski David Wiljer Alexis Lund Amelia Di Meo Joseph Cafazzo Masoom Haider 《Canadian Urological Association journal》2021,15(4):108
IntroductionAs we progress to an era when patient autonomy and shared decision-making are highly valued, there is a need to also have effective patient-centered communication tools. Radiology reports are designed for clinicians and can be very technical and difficult for patients to understand. It is important for patients to understand their magnetic resonance imaging (MRI) report in order to make an informed treatment decision with their physician. Therefore, we aimed to create a patient-centered prostate MRI report to give our patients a better understanding of their clinical condition.MethodsA prototype patient-centered radiology report (PACERR) was created by identifying items to include based on opinions sought from a group of patients undergoing prostate MRI and medical experts. Data was collected in semi-structured interviews using a salient belief question. A prototype PACERR was created in collaboration with human factors engineering and design, medical imaging, biomedical informatics, and cancer patient education groups.ResultsFifteen patients and eight experts from urology, radiation oncology, radiology, and nursing participated in this study. Patients were particularly interested to have a report with laymen terms, concise language, contextualization of values, definitions of medical terms, and next course of action. Everyone believed the report should include the risk of MRI findings actually being cancer in the subsequent biopsy.ConclusionsA prostate MRI PACERR has been developed to communicate the most important findings relevant to decision-making in prostate cancer using patient-oriented design principles. The ability of this tool to improve patient knowledge and communication will be explored. 相似文献
53.
Sara W. Jones PhD Susanne Darra PhD Mike Davies Catherine Jones MSc student Wendy Sunderland-Evans Mike R. M. Ward PhD 《Health & social care in the community》2021,29(4):1115-1125
Children of young and socially disadvantaged parents are more likely to experience adverse outcomes. In response to this, a unique young families’ project in Swansea, UK, was created, which drew together a team of multi-agency professionals, to support people aged 16–24 from 17 weeks of pregnancy throughout 1,001 days of the child's life. The aim of the JIGSO (the Welsh word for Jigsaw) project is for young people to reach their potential as parents and to break the cycle of health and social inequality. This evaluation analysed routinely collected data held by the project from January 2017 to December 2018 exploring health and social outcomes, including smoking and alcohol use in pregnancy, breastfeeding, maternal diet and social services outcomes. Outcomes were compared to local and national averages, where available. Data relating to parenting knowledge and skills were available via records of 10-point Likert scales, one collected at the start of the JIGSO involvement and one around 4–6 months later. Findings showed higher than average levels of breastfeeding initiation and lower smoking and alcohol use in pregnancy. Parents also reported enhanced knowledge and confidence in their child care skills, as well as improved family relationships. Parents with high levels of engagement with JIGSO also appeared to have positive outcomes with Social Services (their child's name was removed from child protection register or their case was closed to social services). This was a post-hoc evaluation, not an intervention study or trial, and thus findings must be interpreted with caution. Despite this, the findings are promising and more prospective research exploring similar services is required. 相似文献
54.
RNA interference (RNAi) is a flexible gene silencing mechanism that responds to double-stranded RNA by suppressing homologous genes. Here, we report the characterization of RNAi effector complexes (RISCs) that contain small interfering RNAs and microRNAs (miRNAs). We identify two putative RNA-binding proteins, the Drosophila homolog of the fragile X mental retardation protein (FMRP), dFXR, and VIG (Vasa intronic gene), through their association with RISC. FMRP, the product of the human fragile X locus, regulates the expression of numerous mRNAs via an unknown mechanism. The possibility that dFXR, and potentially FMRP, use, at least in part, an RNAi-related mechanism for target recognition suggests a potentially important link between RNAi and human disease. 相似文献
55.
Mike E. C. Robbins Darryl Campling Elizabeth Whitehouse John W. Hopewell Adam Michalowski 《Cancer chemotherapy and pharmacology》1990,27(3):211-218
Summary Groups of mature Large White female pigs, approximately 10 months of age, received single intravenous infusions of 1.5, 2 or 2.5 mg/kg body weight (equivalent to90, 120 and 150 mg/m2) cisplatin. Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured before and at 4 weeks after cisplatin infusion by renography using [99 mTc]-DTPA (diethylenetriamminepentaacetic acid and iodohippurate sodium I 131, respectively. The left kidney of each cisplatin-treated animal plus that of four age-matched control pigs was then removed surgically,and GRF and ERPF were measured in the remaining kidney at 4 weekly intervals for up to 24 weeks after unilateral nephrectomy (UN). The pigs treated with cisplatin exhibited no consistent change in either GFR or ERPF at 4 weeks after treatment. A histological evaluation of kidneys from animals treated with 2mg/kg cisplatin that had been removed at UN revealed both tubular and glomerular lesions. The latter consisted of cell proliferation on the parietal surface of the urinary space; damage to the S1 portion of the proximal convolution was also noted. Following UN there was a pronounced dose-dependent reduction in the functional status of the remaining kidney such that the increase in GRF and ERPF in pigs initially receiving 2.5 mg/kg cisplatin was <50% of that seen in age-matched UN controls. Moreover, the glomerular lesions observed at 4 weeks after cisplatin infusion had apparently progressed to glomerular hyalinisation by 24 weeks after UN. Thus, prior treatment with cisplatin may cause a permanent reduction in renal functional reserve that may be clinically silent until exposure to an additional nephrotoxic insult.This study was supported by the Cancer Research Campaign 相似文献
56.
57.
Kirsten Barnicot Jennie Parker Sarah Kalwarowsky Eloise Stevens Jane Iles Paul Ramchandani Mike Crawford 《Psychology and psychotherapy》2023,96(2):480-503
Objectives
We explored mothers' and clinicians' experiences of a video feedback intervention adapted for perinatal ‘personality disorder’ (VIPP-PMH) and the acceptability of a randomised controlled trial (RCT) examining its effectiveness.Design
In-depth qualitative interviews with participants from a two-phase feasibility study of the VIPP-PMH intervention. Participants were mothers experiencing enduring difficulties in managing emotions and relationships, consistent with a ‘personality disorder’, and their 6- to 36-month-old children.Methods
Forty-four qualitative interviews were conducted, including all nine mothers receiving VIPP-PMH during the pilot phase, 25 of the 34 mothers participating in the RCT (14 allocated to the VIPP-PMH arm and 9 from the control arm), 11 of the 12 clinicians delivering VIPP-PMH and one researcher. Interview data were thematically analysed.Results
Mothers described feeling motivated to take part in the research and understood the need for randomisation. Research visits were largely experienced positively, with some suggestions for improvement in questionnaire timing and accessibility. Almost all mothers initially felt anxious about being filmed, but reported positive experiences of the intervention, particularly valuing its non-judgemental, positive and child-focussed nature, their supportive relationship with the therapist and the insights they gained on their child.Conclusions
The findings indicate the likely feasibility and acceptability of undertaking a future definitive RCT of the VIPP-PMH intervention in this population. In designing a future trial, a positive and non-judgemental therapeutic relationship will be important to allay mothers' anxieties about being filmed, and careful consideration should be given to the timing and accessibility of questionnaires used. 相似文献58.
Mr. Mike Gorman M.A. 《Community mental health journal》1976,12(2):119-127
In 1975, twelve years after enactment of the Community Mental Health Centers Act, we find one of the greatest obstacles to fulfillment of our hopes to be pervasive hostility to acceptance of the mentally ill in many communities. The River Region Program has hurdled this obstacle by breaking the artificially large mental health catchment areas into manageable segments of 16 smaller service areas close to the people it serves in seven counties of Kentucky. In each of these service areas it has involved a broad spectrum of citizens in the planning of every service. All of this is of particular relevance today in light of the Supreme Court's D,onaldson decision, that mentally ill persons cannot be confined involuntarily if they are not dangerous and can live safely in the outside world. The outside world must be prepared to receive these people, and we in the mental health field must do our job in this vital preparation.Mr. Gorman originally presented this paper as a speech at the Annual Dinner, of the River Region Mental Health — Mental Retardation Board in Louisville, Kentucky, on June 20, 1975. 相似文献
59.
60.
Francesco Izzo Paolo Marra Gerardo Beneduce Giuseppe Castello Paolo Vallone Vincenzo De Rosa Franco Cremona C Mark Ensor Frederick W Holtsberg John S Bomalaski Mike A Clark Chaan Ng Steven A Curley 《Journal of clinical oncology》2004,22(10):1815-1822
PURPOSE: Recently, we reported that a large number of human hepatocellular cancer (HCC) cell lines were auxotrophic for arginine. Here we report the results obtained with the amino acid-degrading enzyme arginine deiminase (ADI) conjugated to polyethylene glycol (ADI-SS PEG 20,000 mw) as a means of lowering plasma arginine to treat HCC. The study was a cohort dose-escalation phase I/II study. PATIENTS AND METHODS: Pharmacodynamic studies indicated an ADI-SS PEG 20,000 mw dose level of 160 U/m(2) was sufficient to lower plasma arginine from a resting level of approximately 130 micromol/L to below the level of detection (< 2 micromol/L) for more than 7 days, a dose later defined as the optimal biologic dose. All patients were to receive three cycles at the optimum biologic dose. RESULTS: This therapy was well tolerated, even in patients who had no detectable plasma arginine for 3 continuous months of therapy. Of the 19 patients enrolled, two had a complete response, seven had a partial response, seven had stable disease, and three had progressive disease. The median survival for the 19 patients enrolled on this study was 410 days, with four patients still alive at present (> 680 days). CONCLUSION: Elimination of all detectable plasma arginine in patients with HCC was well tolerated and seemed to be effective in the treatment of some patients with HCC. Further testing of ADI-SS PEG 20,000 mw in a larger population of individuals with HCC as well as other human tumors auxotrophic for arginine is warranted. 相似文献